ArticleHeliyon2024
Blockchain based solution for secure information sharing in pharma supply chain management.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceutical supply chain management (PSCM) aims to alleviate logistical challenges. However, traditional online pharma systems face issues during implementation, particularly regarding transparency and fostering mutual trust among stakeholders. The primary security goals for a supply chain management (SCM) solution are ensuring authentication, confidentiality, data provenance, and auditability. The proposed blockchain-based solution (BPSCM) is implemented in three phases: registration, pharmaceutical product circulation, and secure payment. The registration phase computes the identification number upon the hashed private key along with the Edwards-curve digital signature algorithm (EdDSA) for all the stakeholders. The pharm product circulation phase implements the transactions among the participants by developing smart contracts where cryptographic operators ensure data provenance. The security analysis demonstrates that the framework effectively mitigates impersonation and collusion attacks. Performance metrics, including gas consumption, throughput, latency, and computational cost, were examined and compared to standard PSCM frameworks to evaluate the BPSCM's effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.